⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CELU News
Celularity Inc. Class A Common Stock
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
globenewswire.com
CELU
CELUW
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products
globenewswire.com
CELU
NXGL
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities
globenewswire.com
CELU
CELUW
NXGL
Form 8-K
sec.gov
CELU
CELUW
NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products
globenewswire.com
CELU
NXGL
Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy
globenewswire.com
CELU
CELUW
Form 8-K
sec.gov
CELUW
CELU
Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses
globenewswire.com
CELU
CELUW
Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations
globenewswire.com
CELU
Celularity Announces Closing of Financing Transactions
globenewswire.com
CELU